Palisade Bio (PALI) Return on Sales (QoQ) (2011 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 3.00 |
| Sep 30, 2023 | 3.00 |
| Jun 30, 2023 | -48.00 |
| Sep 30, 2022 | -3,458.00 |
| Jun 30, 2022 | 3,022.00 |
| Dec 31, 2020 | -640.00 |
| Sep 30, 2020 | 2.00 |
| Jun 30, 2020 | -408.00 |
| Mar 31, 2020 | 521.00 |
| Dec 31, 2019 | -5.00 |
| Sep 30, 2019 | -603.00 |
| Jun 30, 2019 | 730.00 |
| Mar 31, 2019 | -258.00 |
| Dec 31, 2018 | 113.00 |
| Sep 30, 2018 | -819.00 |
| Jun 30, 2018 | 925.00 |
| Mar 31, 2018 | -924.00 |
| Dec 31, 2017 | 1,020.00 |
| Sep 30, 2017 | 660.00 |
| Jun 30, 2017 | 52.00 |
| Mar 31, 2017 | -1,074.00 |
| Dec 31, 2016 | 1,390.00 |
| Sep 30, 2016 | -399.00 |
| Jun 30, 2016 | 986.00 |
| Mar 31, 2016 | -734.00 |
| Dec 31, 2015 | 345.00 |
| Sep 30, 2015 | -80.00 |
| Jun 30, 2015 | -443.00 |
| Mar 31, 2015 | -648.00 |
| Dec 31, 2014 | -193.00 |
| Sep 30, 2014 | -113.00 |
| Jun 30, 2014 | 562.00 |
| Mar 31, 2014 | -61.00 |
| Dec 31, 2013 | 347.00 |
| Sep 30, 2013 | -162.00 |
| Jun 30, 2013 | -1,435.00 |
| Mar 31, 2013 | 1,057.00 |
| Dec 31, 2012 | -1,071.00 |
| Sep 30, 2012 | 15.00 |
| Jun 30, 2012 | -15.00 |
| Mar 31, 2012 | -7.00 |
| Dec 31, 2011 | 22.00 |